Viewing Study NCT00345059


Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2026-01-23 @ 10:50 PM
Study NCT ID: NCT00345059
Status: TERMINATED
Last Update Posted: 2016-01-14
First Post: 2006-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer
Sponsor: National Cancer Institute, Naples
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Non-Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None second line View
None monochemotherapy View
None combination chemotherapy View
None platinum refractory View
None previously treated View